Innospec Inc. has grown revenue −2.9% a year over three years and 7.7% a year over five, with earnings per share compounding at −1.1%. Revenue growth, 3-year annual rate: −2.9% (Specialty Chemicals median +3.3%). Revenue growth, 5-year rate: +7.7%, growth has slowed since the five-year average. Earnings per share, 3-year rate: −1.1%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 17, FY2009 to FY2025, as filed.

IOSPInnospec Inc.

Basic Materials

$95.59+23% 1Y

$95.59

$65.1252 weeks$98.69

Is it growing?

Mixed

Neither accelerating nor breaking down: earnings up +528% year on year, but operating margin narrowing (−2.2 points).

1 good, 1 to watch, 1 neutral

Revenue trend+3% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +8% a year.

Earnings trend+528% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction−2.2 points operating

Trailing-twelve-month operating margin, 6.9% now against 9.1% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbehind 89% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is IOSP growing?

Innospec Inc. has grown revenue −2.9% a year over three years and 7.7% a year over five, with earnings per share compounding at −1.1%.

−2.9%

Revenue growth, 3-year annual rate · Specialty Chemicals median +3.3% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +7.7%
Revenue growth, 5-year rate · −2.9% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: −1.1%
Earnings per share, 3-year rate · revenue −2.9% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed